Patent · US Expired

Human monoclonal antibodies against human IL-4

US7740843B2 · kind B2 · utility

1Cited by

2References

4Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Jose M. Carballido Herrera · Allschwil, CH
Jan E. de Vries · Los Altos, US
Christoph Schwaerzler · La Valette-du-Var, FR

Key dates

Filing date	Aug 2, 2005
Grant date	Jun 22, 2010
Priority date	—
Expiry date	Feb 7, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies which are specific for human interleukin-4 and their use in the treatment of IL-4 and/or IgE mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.